XAGE-5 Inhibitors
XAGE-5 inhibitors are chemical compounds specifically designed to target and inhibit the activity of XAGE-5, a protein belonging to the XAGE (X Antigen Family) of proteins. The XAGE family is generally characterized by its role in cellular processes such as gene expression regulation, particularly in tissues where expression is highly specialized or limited. XAGE-5, like other members of this family, is known for its restricted expression patterns and potential involvement in regulating transcription or signaling pathways that impact cellular growth, differentiation, or response to environmental stimuli. The exact biological function of XAGE-5 is not yet fully characterized, but its involvement in modulating gene expression or other nuclear activities suggests it plays a role in maintaining cellular homeostasis in specific tissue types or developmental stages.
Inhibitors of XAGE-5 function by binding to critical regions of the protein, preventing it from engaging in its normal interactions with DNA, other proteins, or transcriptional machinery. By blocking these interactions, XAGE-5 inhibitors can interfere with the regulatory functions that XAGE-5 may have in controlling gene expression or cellular responses to various internal or external signals. This inhibition could lead to changes in how genes are expressed or silenced, potentially impacting cellular pathways that rely on the precise regulation of gene activity. The structural study of XAGE-5 inhibitors provides important insights into how these compounds affect the function of XAGE-5 at the molecular level, including their binding affinity, specificity, and ability to modulate XAGE-5's role in cellular regulation. Understanding these dynamics is key to comprehending how XAGE-5 inhibition influences broader processes such as cell growth, differentiation, and molecular signaling networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of the PI3K/Akt signaling pathway. This pathway modulates various cellular processes including gene expression. Inhibition of PI3K/Akt can decrease the expression of XAGE-5 through downstream effects on transcriptional regulators. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β signaling pathway which can impact cellular differentiation and proliferation. By inhibiting this pathway, the expression of XAGE-5 could be indirectly decreased due to altered cellular states that affect gene expression profiles. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can lead to the downregulation of multiple genes involved in cell growth and proliferation. The inhibition of mTOR signaling may result in decreased XAGE-5 expression due to changes in cellular growth conditions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A specific inhibitor of MEK1/2, which are key components of the MAPK/ERK pathway. By inhibiting MEK1/2, U0126 may lead to a reduction in XAGE-5 expression as a consequence of the attenuated signaling cascade. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cytoskeleton dynamics and cellular motility. The inhibition of ROCK signaling could indirectly reduce the expression of XAGE-5 by altering the cellular architecture and related signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, part of the MAPK signaling network. Inhibition of JNK can modulate gene expression profiles, which may include a decrease in XAGE-5 expression due to changes in transcriptional activity. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A γ-secretase inhibitor, affecting Notch signaling. Disruption of Notch signaling can lead to altered gene expression patterns, potentially reducing the levels of XAGE-5 in cells that rely on this pathway for gene regulation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor which can lead to cell cycle arrest and apoptosis. By inhibiting the proteasome, the degradation of proteins that regulate gene expression is affected, which may result in the downregulation of XAGE-5. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that disrupts cell division and can influence gene expression. By inhibiting Aurora kinase, ZM-447439 could indirectly decrease XAGE-5 levels due to the impact on cell cycle progression and associated gene regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can cause a reduction in Akt signaling, influencing various cellular processes including gene expression which could lead to the decreased expression of XAGE-5. | ||||||